Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Hepatic steatosis, Hypertriglyceridemia, Low HDL ("good") cholesterol (decreased hdl cholesterol concentration), and Short stature and others; and common findings: Type II diabetes mellitus.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 3 | Hepatic steatosis, Low HDL ("good") cholesterol (decreased hdl cholesterol concentration), Elevated circulating hepatic transaminase concentration |
PCYT1A function has not been fully characterized.
Lipodystrophy, congenital generalized, type 5 is associated with mutations in the PCYT1A gene on chromosome 3.
Genetic testing for PCYT1A is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 12 always present features, 1 common feature.
No clinical trials have been registered for lipodystrophy, congenital generalized, type 5.
8 publications have been identified in PubMed for lipodystrophy, congenital generalized, type 5. Research spans Case Report / Case Series (38%), Other (13%), and Review / Meta-Analysis (13%).
Hwang M (2026). [PMID: 41751861](https://pubmed.ncbi.nlm.nih.gov/41751861/). *International journal of molecular sciences*. [Case Report / Case Series]
Bauer R (2025). [PMID: 40832409](https://pubmed.ncbi.nlm.nih.gov/40832409/). *medRxiv : the preprint server for health sciences*. [Case Report / Case Series]
Lima JG (2025). [PMID: 41272755](https://pubmed.ncbi.nlm.nih.gov/41272755/). *Diabetology & metabolic syndrome*. [Other]
Sued Leão I (2025). [PMID: 40860570](https://pubmed.ncbi.nlm.nih.gov/40860570/). *JCEM case reports*. [Case Report / Case Series]
Foss-Freitas M (2025). [PMID: 40835790](https://pubmed.ncbi.nlm.nih.gov/40835790/). *Current diabetes reports*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:03 PM UTC
Online Mendelian Inheritance in Man
Lab test results | 2 | Decreased adiponectin level, Elevated circulating hepatic transaminase concentration |
Hormones | 2 | Insulin resistance, Type II diabetes mellitus |
Growth and development | 1 | Short stature |
Skin | 1 | Loss of subcutaneous adipose tissue in limbs |
Arms and legs | 1 | Loss of subcutaneous adipose tissue in limbs |
Rajan R (2024). [PMID: 39550450](https://pubmed.ncbi.nlm.nih.gov/39550450/). *Scientific reports*. [Clinical Trial Publication]
Santos JL (2024). [PMID: 39669119](https://pubmed.ncbi.nlm.nih.gov/39669119/). *Frontiers in genetics*. [Epidemiology / Natural History]
Saxena A (2024). [PMID: 39444451](https://pubmed.ncbi.nlm.nih.gov/39444451/). *Frontiers in endocrinology*. [Basic Science / Preclinical]